You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1163 A novel bispecific antibody-drug conjugate targeting PTK7 and TROP2, BCG033, demonstrates preclinical efficacy against triple-negative breast cancer xenografts

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immuno-Conjugates and Chimeric Molecules
1163 A novel bispecific antibody-drug conjugate targeting PTK7 and TROP2, BCG033, demonstrates preclinical efficacy against triple-negative breast cancer xenografts

 

Online download statistics by month:

Online download statistics by month: November 2023 to August 2025

AbstractFullPdf
Nov 2023176024
Dec 202390014
Jan 2024105017
Feb 20246207
Mar 2024224013
Apr 2024112018
May 202480011
Jun 2024101014
Jul 202474020
Aug 20245206
Sep 20246809
Oct 2024100017
Nov 202435019
Dec 2024102023
Jan 2025192023
Feb 202550021
Mar 2025009
Apr 20250015
May 20250012
Jun 20251011
Aug 2025100
Total16250303